On Thursday, Jan. 11, the Center for International Business and the Health Care Club at the Tuck School of Business will host a conference on globalization and the pharmaceutical and biotechnology ("biopharma") industries. The conference will begin at noon in the Cohen Great Hall at Tuck with a keynote luncheon. Peter R. Dolan, Tuck '80, former chairman and CEO of Bristol-Myers Squibb, will deliver the keynote address, "The Effects of Globalization on the Biopharma Industry."
Biopharma companies increasingly are searching the world both for new markets and for opportunities to reduce drug development costs, efforts that are likely to interact with pricing strategies, sourcing decisions, and company structure. The conference will address questions including:
The keynote luncheon will be followed by two panel discussions. The first, "The Challenges of Drug Pricing in Global Markets," will be held at 1:30 p.m. in the Shapiro classroom at Tuck. Panelists include David Meeker, president of lysosomal disorder therapeutics at Genzyme, and John Cullity, senior director of strategic pricing at Sanofi-Aventis. The panel, "Opportunities to Reduce Drug Costs in a Global Economy," will be held after a short break in the same location.
Panelists include: Kenneth Kaitin, director of the Center for the Study of Drug Development, Tufts University; Anne Sullivan, Tuck '95, senior director of business development, Sepracor; and Anil Khurana, director of operations strategy and private equity, PRTM. Stephen Spielberg, dean of Dartmouth Medical School, will moderate.
The conference is free and open to the public. For more information or to register, visit www.tuckhealthcare.com or call 646-9306.
By LISA MILLER
Questions or comments about this article? We welcome your feedback.
Last Updated: 12/17/08